Research & Development

Respiratory

PYN5 to treat respiratory tract infections (RTI's)

The three plant extract formulation upon which PYN5 is based is licensed in China for the treatment of RTI's such as common colds, flu, chronic bronchitis, RSV infection and pneumonia, and is one of the commonly prescribed, licensed drugs in that ountry. The combination of its apparent anti-viral, anti-bacterial and anti-inflammatory properties are widely reported and numerous clinical studies show it to be effective in reducing the duration of viral infections with minimal adverse reactions.